BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 34816983)

  • 1. Prevalence of symptoms of COVID-19 in the state of Rio Grande do Sul: results of a population-based study with 18,000 participants.
    Mesenburg MA; Hallal PC; Menezes AMB; Barros AJD; Horta BL; Hartwig FP; Jacques N; Pellanda LC; Zelmanowicz AM; Vergani DOP; Ries EF; Harter J; Martínez-Mesa J; Carneiro M; Estima SL; Heck TG; Silveira MFD
    Rev Saude Publica; 2021; 55():82. PubMed ID: 34816983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of Loss of Smell and/or Taste and other Otorhinolaryngology Symptoms in COVID-19 Patients.
    Shrestha I; Mishra A; Mishra A; Bista M; Acharya J
    Kathmandu Univ Med J (KUMJ); 2021; 19(74):173-179. PubMed ID: 34819431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Day-by-day symptoms following positive and negative PCR tests for SARS-CoV-2 in non-hospitalized healthcare workers: A 90-day follow-up study.
    Nielsen KJ; Vestergaard JM; Schlünssen V; Bonde JP; Kaspersen KA; Biering K; Carstensen O; Greve T; Hansen KK; Dalbøge A; Flachs EM; Jespersen S; Hansen ML; Mikkelsen S; Thomsen MK; Redder JD; Würtz ET; Østergaard L; Erikstrup C; Kolstad HA
    Int J Infect Dis; 2021 Jul; 108():382-390. PubMed ID: 34022336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic non-communicable diseases and COVID-19: EPICOVID-19 Brazil results.
    Mesenburg MA; Hallal PC; Menezes AMB; Barros AJD; Horta BL; Barros FC; Hartwig FP; Jacques N; Silveira MFD
    Rev Saude Publica; 2021; 55():38. PubMed ID: 34105606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Symptoms reported by SARS-CoV-2 seropositive and seronegative healthcare and administrative employees in Denmark from May to August 2020.
    Kaspersen KA; Greve T; Nielsen KJ; Jespersen S; Mikkelsen S; Vestergaard JM; Redder JD; Tolstrup M; Thomsen MK; Møller HJ; Østergaard L; Kolstad HA; Erikstrup C
    Int J Infect Dis; 2021 Aug; 109():17-23. PubMed ID: 34126235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distorted chemosensory perception and female sex associate with persistent smell and/or taste loss in people with SARS-CoV-2 antibodies: a community based cohort study investigating clinical course and resolution of acute smell and/or taste loss in people with and without SARS-CoV-2 antibodies in London, UK.
    Makaronidis J; Firman C; Magee CG; Mok J; Balogun N; Lechner M; Carnemolla A; Batterham RL
    BMC Infect Dis; 2021 Feb; 21(1):221. PubMed ID: 33632171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross sectional study of the clinical characteristics of French primary care patients with COVID-19.
    Sebo P; Tudrej B; Lourdaux J; Cuzin C; Floquet M; Haller DM; Maisonneuve H
    Sci Rep; 2021 Jun; 11(1):12492. PubMed ID: 34127693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in the prevalence of COVID-19 infection in Rio Grande do Sul, Brazil: repeated serological surveys.
    Hallal PC; Horta BL; Barros AJD; Dellagostin OA; Hartwig FP; Pellanda LC; Struchiner CJ; Burattini MN; Silveira MFD; Menezes AMB; Barros FC; Victora CG
    Cien Saude Colet; 2020 Jun; 25(suppl 1):2395-2401. PubMed ID: 32520284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Symptom presentation of SARS-CoV-2-positive and negative patients: a nested case-control study among patients calling the emergency medical service and medical helpline.
    Moeller AL; Mills EHA; Collatz Christensen H; Gnesin F; Blomberg SNFN; Zylyftari N; Jensen B; Ringgren KB; Broccia MD; Bøggild H; Torp-Pedersen C
    BMJ Open; 2021 May; 11(5):e044208. PubMed ID: 34031110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real Asymptomatic SARS-CoV-2 Infection Might Be Rare: Importance of Careful Interviews and Follow-up.
    Jeong TH; Pak C; Ock M; Lee SH; Son JS; Jeon YJ
    J Korean Med Sci; 2020 Sep; 35(37):e333. PubMed ID: 32959547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A structural equation model to examine the clinical features of mild-to-moderate COVID-19: A multicenter Italian study.
    Barillari MR; Bastiani L; Lechien JR; Mannelli G; Molteni G; Cantarella G; Coppola N; Costa G; Trecca EMC; Grillo C; La Mantia I; Chiesa-Estomba CM; Vicini C; Saussez S; Nacci A; Cammaroto G
    J Med Virol; 2021 Feb; 93(2):983-994. PubMed ID: 32710639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population-level seropositivity trend for SARS-Cov-2 in Rio Grande do Sul, Brazil.
    Barros AJD; Victora CG; Menezes AMB; Horta BL; Barros FC; Hartwig FP; Victora GD; Vidaletti LP; Silveira MF; Mesenburg MA; Jacques N; Struchiner CJ; Brust FR; Dall'Agnol MM; Delamare APL; François CHR; Ikeda MLR; Pellegrini DCP; Reuter CP; Silva SGD; Dellagostin OA; Hallal PC
    Rev Saude Publica; 2021; 55():78. PubMed ID: 34816981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ear nose throat-related symptoms with a focus on loss of smell and/or taste in COVID-19 patients.
    Sakalli E; Temirbekov D; Bayri E; Alis EE; Erdurak SC; Bayraktaroglu M
    Am J Otolaryngol; 2020; 41(6):102622. PubMed ID: 32629147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Symptom-based early-stage differentiation between SARS-CoV-2 versus other respiratory tract infections-Upper Silesia pilot study.
    Mika J; Tobiasz J; Zyla J; Papiez A; Bach M; Werner A; Kozielski M; Kania M; Gruca A; Piotrowski D; Sobala-Szczygieł B; Włostowska B; Foszner P; Sikora M; Polanska J; Jaroszewicz J
    Sci Rep; 2021 Jun; 11(1):13580. PubMed ID: 34193945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19 prevalence and predictors in United States adults during peak stay-at-home orders.
    Morlock R; Morlock A; Downen M; Shah SN
    PLoS One; 2021; 16(1):e0245586. PubMed ID: 33481900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Should COVID-19 symptoms be used to cohort patients in the emergency department? A retrospective analysis.
    Bijur PE; Friedman BW; Baron SW; Ramasahayam A; Nerenberg R; Sharpe S; Goldstein DY; Esses D
    Am J Emerg Med; 2022 Apr; 54():274-278. PubMed ID: 35220142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Symptoms and symptom clusters associated with SARS-CoV-2 infection in community-based populations: Results from a statewide epidemiological study.
    Dixon BE; Wools-Kaloustian KK; Fadel WF; Duszynski TJ; Yiannoutsos C; Halverson PK; Menachemi N
    PLoS One; 2021; 16(3):e0241875. PubMed ID: 33760821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and Duration of Acute Loss of Smell or Taste in COVID-19 Patients.
    Lee Y; Min P; Lee S; Kim SW
    J Korean Med Sci; 2020 May; 35(18):e174. PubMed ID: 32383370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Self-reported symptoms in healthy young adults to predict potential coronavirus disease 2019.
    Nitecki M; Taran B; Ketko I; Geva G; Yosef R; Toledo I; Twig G; Avramovitch E; Gordon B; Derazne E; Fink N; Furer A
    Clin Microbiol Infect; 2021 Apr; 27(4):618-623. PubMed ID: 33418018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 Seroprevalence in Healthcare Workers of Kaunas Hospitals during the First Wave of the COVID-19 Pandemic.
    Pereckaitė L; Dambrauskienė A; Urbonienė D; Sadauskas S; Petrikonis K; Naudžiūnas A; Vitkauskienė A
    Medicina (Kaunas); 2021 Feb; 57(2):. PubMed ID: 33562085
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.